Home/Filings/4/0001104659-23-021625
4//SEC Filing

Rowinsky Eric K 4

Accession 0001104659-23-021625

CIK 0001429260other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:11 PM ET

Size

4.8 KB

Accession

0001104659-23-021625

Insider Transaction Report

Form 4
Period: 2023-02-10
Rowinsky Eric K
DirectorVice Chairman of the Board
Transactions
  • Purchase

    COMMON STOCK, PAR VALUE $0.001

    2023-02-10$0.83/sh+11,976$10,000931,976 total
Footnotes (1)
  • [F1]The total holdings include 200,000 shares of deferred restricted stock.

Issuer

Fortress Biotech, Inc.

CIK 0001429260

Entity typeother

Related Parties

1
  • filerCIK 0001318886

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:11 PM ET
Size
4.8 KB